Tag
Medicare doesn’t cover new FDA-approved blood tests that could detect Alzheimer’s early. The bipartisan “ASAP Act” aims to change that.

A new study offers one of the most detailed looks yet at how the brain’s molecular landscape shifts over time…

The FDA recently approved a new blood test for Alzheimer’s that researchers say helps doctors diagnose it earlier and at…

Recent research revealed that blood tests for biomarkers of Alzheimer’s are less reliable for Black patients than for other racial…

At HJ25 in L.A., Charles Piller spoke about his book delving into the world of Alzheimer’s research misconduct.

In this webinar, we speak with an investigative journalist and neuroscientist who uncovered widespread Alzheimer’s research misconduct.

Reporters Jeanne Lenzer and Shannon Brownlee discuss their latest work, a three-part series on industry influence at the FDA.

New research on high-density lipoprotein cholesterol may give us more insight into factors that affect cognitive health in aging adults.

•
In this webinar, we’ll speak with an investigative journalist and neuroscientist who uncovered widespread Alzheimer’s research misconduct.

Science reporter Charles Piller discusses how he discovered evidence of a prominent neuroscientist’s research misconduct.
